| abstract |
The present invention relates to a novel heterocyclic compound of general formula ML-M2, which is a pyrazolopyridine derivative which induces FGFR dimerization. M and M2, which may be the same or different, each independently represent a monomer unit M, and L Represents a linking group that covalently couples M1 and M2 to a monomer unit such as the following (Formula M). Its preparation and its therapeutic use. |